Company intelligence / Profile preview

Klear Bio

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Klear Bio is a biotechnology company based in San Diego that is developing a next-generation platform for single-cell multi-omics. The company's core technology, Klear-Seq, is designed to enable high-throughput, high-resolution analysis of cellular heterogeneity to accelerate drug discovery and development. By providing deeper insights into the molecular profiles of individual cells, Klear Bio aims to support the identification of novel biomarkers and therapeutic targets across various diseases, including cancer. The company is led by a team with significant experience in genomics and biotechnology, focusing on scaling single-cell analysis for clinical and research applications.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Klear Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klear Bio.

Explore the full profile